ProfileGDS5678 / 1454628_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 42% 44% 45% 48% 57% 43% 43% 44% 45% 46% 45% 45% 43% 44% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.0148442
GSM967853U87-EV human glioblastoma xenograft - Control 23.0183744
GSM967854U87-EV human glioblastoma xenograft - Control 33.0523845
GSM967855U87-EV human glioblastoma xenograft - Control 43.0741648
GSM967856U87-EV human glioblastoma xenograft - Control 53.4141957
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.0875543
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.0496743
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.0281644
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0236145
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.0642946
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.0372545
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0168845
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.0116743
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.0292244